The treatment of hypertension in patients with erectile dysfunction

被引:25
|
作者
Mikhailidis, DP
Khan, MA
Milionis, HJ
Morgan, RJ
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Mol Pathol & Clin Biochem, London NW3 2QG, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Urol, London NW3 2QG, England
关键词
beta-blockers; diuretics; doxazosin; erectile dysfunction; hypertension;
D O I
10.1185/0300799009117037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is another predictor of erectile dysfunction (ED). This is further evidence supporting a link between the pathogenesis of atherosclerotic disease ann ED. In one study (TOMHS) involving hypertensive patients, the incidence of ED was 14.4%. The drugs used to treat hypertension may cause ED. However, there is little trial-based evidence to indicate which drugs are more likely to cause this side effect. In general, thiazide diuretics and beta-blockers seem to cause ED more often. In contrast, the alpha-blocker doxazosin, has Mot been associated with an increased incidence of ED as a sine effect. Doxazosin also improves urinary flow in patients with benign prostatic hyperplasia (BPH). This condition is common in elderly men as is hypertension and ED. Therefore, doxazosin may present a special advantage among this group of patients. This alpha-blocker would also be a good choice in patients with impaired glucose tolerance/diabetes because it improves insulin sensitivity. Moreover, ED and hypertension are more prevalent among diabetics. On a more speculative note, doxazosin may potentiate the therapeutic impact of specific treatments for ED.
引用
收藏
页码:S31 / S36
页数:6
相关论文
共 50 条
  • [41] Treatment program for erectile dysfunction in patients with cardiovascular diseases
    Israilov, S
    Baniel, J
    Shmueli, J
    Niv, E
    Engelstein, D
    Segenreich, E
    Livne, PM
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 689 - 693
  • [42] The prevalence, etiology, and treatment of hyperprolactinemia in patients with erectile dysfunction
    Marumo, K.
    Miyajima, A.
    Horiguchi, Y.
    Nakagawa, K.
    Oya, M.
    Ohigashi, T.
    Nakashima, J.
    Murai, M.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 127 - 128
  • [43] Erectile dysfunction: etiology and treatment in young and old patients
    Tariq, SH
    Haleem, U
    Omran, ML
    Kaiser, FE
    Perry, HM
    Morley, JE
    CLINICS IN GERIATRIC MEDICINE, 2003, 19 (03) : 539 - +
  • [44] Nebivolol versus other beta blockers in patients with hypertension and erectile dysfunction
    Sharp, Randall P.
    Gales, Barry J.
    THERAPEUTIC ADVANCES IN UROLOGY, 2017, 9 (02) : 59 - 63
  • [45] Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both
    Giuliano, FA
    Leriche, A
    Jaudinot, EO
    de Gendre, AS
    UROLOGY, 2004, 64 (06) : 1196 - 1201
  • [46] Erectile dysfunction and its influence on quality of life in patients with essential hypertension
    Kushiro, T
    Takahashi, A
    Saito, F
    Otsuka, Y
    Soma, M
    Kurihara, T
    Satomura, A
    Saito, T
    Kanmatsuse, K
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (03) : 427 - 430
  • [47] Treatment of hypertension for patients with diastolic dysfunction
    Krishnan, P
    Ventura, HO
    Uber, PA
    Arcement, LM
    Mehra, MR
    CURRENT OPINION IN CARDIOLOGY, 2003, 18 (04) : 272 - 277
  • [48] The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners
    Brock, Gerald
    Chan, John
    Carrier, Serge
    Chan, Melanie
    Salgado, Luis
    Klein, Alexander H.
    Lang, Clement
    Horner, Richard
    Gutkin, Stephen
    Dickson, Ruth
    BJU INTERNATIONAL, 2007, 99 (02) : 376 - 382
  • [49] Treatment of Erectile Dysfunction: Update
    Raina, Rupesh
    Pahlajani, Geetu
    Agarwal, Ashok
    Zippe, Craig D.
    AMERICAN JOURNAL OF MENS HEALTH, 2007, 1 (02) : 126 - 138
  • [50] Surgical treatment for erectile dysfunction
    Nagao, K.
    Nakajima, K.
    Tai, T.
    Kobayashi, H.
    Ishii, N.
    JOURNAL OF MENS HEALTH, 2011, 8 : S102 - S102